EWTX270115C00055000
EWTX Jan 15 2027 55.00 Call
optionOPRA
InactiveAug 20, 2026
4.20USD+107.921%(+2.18)1Vol7OI
Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
55
Expiration
Jan 15, 2027
DTE
100d
Moneyness
OTM
Intrinsic
$0.00
EWTX 55 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | $0.15 | +0.00% | 20 | 179 |
| Nov 20, 2026 | 44d | $1.20 | -55.22% | 1 | 344 |
| Dec 18, 2026 | 72d | $2.05 | +24.24% | 1 | 3 |
| Jan 15, 2027 | 100d | $4.20 | +107.92% | 1 | 7 |
| Feb 19, 2027 | 135d | — | — | 0 | 0 |
| Mar 19, 2027 | 163d | $2.90 | -46.30% | 1 | 2 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.